| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $99,157,365 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1HD087226 | NICHD Cooperative Multicenter Neonatal Research Network - Utah Center | 000 | 11 | NIH | 5/1/2026 | $338,671 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25TR004388 | Biomedical Research Innovation and Development to Grow Excellence in Science-Undergraduate Program (BRIDGE UP) | 000 | 4 | NIH | 5/1/2026 | $108,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31GM153113 | Human COX7B Contains a cAMP-Responsive Riboswitch that Modulates Oxidative Phosphorylation | 000 | 2 | NIH | 4/9/2026 | $3,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY036877 | The role of centriole linkage in retinal degeneration and hearing loss | 000 | 2 | NIH | 4/6/2026 | $462,430 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25DK145420 | Haumana 'O Pasifika Homeostasis Program | 000 | 1 | NIH | 5/5/2026 | $108,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30DA065457 | Relations and Recovery: A social network analysis of Native mothers navigating substance use | 002 | 1 | NIH | 3/25/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI181713 | Regulation and Manipulation of Innate Immunity During HIV Infection | 000 | 3 | NIH | 4/7/2026 | $694,996 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI181021 | Immunoregulatory roles for exosomes in the gastrointestinal tract | 000 | 3 | NIH | 4/27/2026 | $767,043 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K76AG083304 | Advancing patient-centered decision making in older adults with venous thromboembolism | 000 | 3 | NIH | 5/7/2026 | $243,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 000 | 1 | NIH | 4/8/2026 | $44,201 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32MH140490 | Influence of social environment on the neural mechanisms of sickness | 000 | 1 | NIH | 5/7/2026 | $79,348 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA279973 | PREVENT - Practice-based Approaches to Promote HPV Vaccination | 000 | 4 | NIH | 5/7/2026 | $622,575 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM150766 | Integrated mass spectrometry-based chemoproteomic and genomic technologies for studying dynamic kinase interactomes | 000 | 4 | NIH | 4/6/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM133772 | Visualizing the Mechanisms of Protein Quality Control | 000 | 8 | NIH | 5/7/2026 | $421,960 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA310722 | Cis-Regulatory Role of Alternative Promoters in Cancer | 001 | 1 | NIH | 4/17/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI185994 | Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice | 000 | 2 | NIH | 4/2/2026 | $192,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31ES038448 | Air pollution mixtures and pregnancy: assessing exposure, estimating risk, and predicting susceptibility with machine learning | 001 | 1 | NIH | 5/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA255790 | Cancer invasion: reciprocity between the extracellular matrix and intrinsic ERK signaling | 000 | 5 | NIH | 5/7/2026 | $461,852 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1HD034208 | UofU Maternal-Fetal Medicine Units (MFMU) Network: Clinical Centers | 000 | 32 | NIH | 4/7/2026 | $321,101 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23EY032577 | Improving Glaucoma Care Using a Scalable Decision Support System | 000 | 5 | NIH | 4/6/2026 | $270,321 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EB038025 | Binding-Induced Enzyme Activation for Prodrug Therapy of HER2 Variants | 000 | 2 | NIH | 5/7/2026 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30AI191743 | Directed evolution of a nascent immune function | 001 | 1 | NIH | 4/2/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R38HL167282 | Utah Stimulating Access to Research in Residency | 000 | 4 | NIH | 4/2/2026 | $226,423 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DC021938 | Biomechanical Mechanisms of Benign Paroxysmal Positional Vertigo | 000 | 2 | NIH | 4/1/2026 | $501,586 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25GM154387 | Genetics at Work: Science Careers and In-progress Solutions to Modern Health Challenges | 000 | 3 | NIH | 4/27/2026 | $270,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R61MH135109 | Capturing Autobiographical memory formation in People moving Through real-world spaces Using synchronized wearables and intracranial Recordings of EEG | 000 | 3 | NIH | 4/24/2026 | $890,660 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 002 | 1 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AG094290 | Age-Dependent CD7 Functions in T Cell Responses | 002 | 1 | NIH | 4/1/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM141372 | Kinase Control of Synergistic Cell Migration Mechanics | 000 | 5 | NIH | 4/2/2026 | $308,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167919 | The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation | 000 | 4 | NIH | 4/27/2026 | $651,800 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25HL161608 | Summer Undergraduate Research Experience (SURE) | 000 | 4 | NIH | 4/2/2026 | $163,620 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 001 | 3 | NIH | 4/13/2026 | $15,660 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32DC022517 | Utilizing Receptor-defined Odor Coding Channels to Understand Inhibitory Circuit Organization | 000 | 2 | NIH | 4/1/2026 | $79,348 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA131261 | Studying the initiation, progression and therapy of lung cancer in mouse models | 001 | 14 | NIH | 4/16/2026 | $38,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA246183 | Circulating Cell-Free DNA as a Personalized Biomarker to Diagnose and Monitor Glioblastoma Extension | 001 | 7 | NIH | 4/16/2026 | $35,182 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG098947 | Decision-Making Capacity Assessment and Inclusive Decision-Making for Older Persons with Capacity Challenges | 001 | 1 | NIH | 4/24/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA212415 | Transcriptional Regulation of Lung Cancer Identity | 001 | 9 | NIH | 4/16/2026 | $38,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21MH138856 | Isoform-Specific LEF1 Function in Hypothalamic Neurogenesis and Behavior | 000 | 1 | NIH | 4/17/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259686 | A tissue viability imaging biomarker for use in non-invasive breast cancer therapy | 001 | 5 | NIH | 4/16/2026 | $60,068 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 001 | 5 | NIH | 4/16/2026 | $35,962 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31CA310722 | Cis-Regulatory Role of Alternative Promoters in Cancer | 000 | 1 | NIH | 4/17/2026 | $40,908 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 001 | 4 | NIH | 3/11/2026 | $54,029 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA176839 | Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy | 000 | 9 | NIH | 4/17/2026 | $385,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 001 | 3 | NIH | 4/16/2026 | $40,769 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AG098947 | Decision-Making Capacity Assessment and Inclusive Decision-Making for Older Persons with Capacity Challenges | 000 | 1 | NIH | 4/17/2026 | $423,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R25GM161925 | PULSE (Program Understanding and Learning through Strategic Evaluation) | 000 | 1 | NIH | 3/11/2026 | $105,987 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DK143313 | Implementing Social Drivers of Health Screening and Interventions to Reduce Health Disparities in Chronic Liver Disease | 000 | 1 | NIH | 3/19/2026 | $210,189 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY031959 | Connectivity and function of inhibitory neurons in the primate visual cortex | 000 | 6 | NIH | 4/17/2026 | $653,946 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R38HL167282 | Utah Stimulating Access to Research in Residency | 001 | 4 | NIH | 4/17/2026 | $4,621 |
|
